TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T93509	Calcitonin gene-related peptide 1	D0G5ME	Telcagepant	Phase 2	11319053	C26H27F5N6O3	566.5	C1C[C@H](C(=O)N(C[C@@H]1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5	Ki ~ 100000 nM	Poor binder
T93509	Calcitonin gene-related peptide 1	B7MSA3	4-Bromo-N-[(3,5-difluorophenyl)methyl]-6-(1,1-dioxothiazinan-2-yl)-3-methoxypyridine-2-carboxamide	Investigative	57397325	C18H18BrF2N3O4S	490.3	COC1=C(N=C(C=C1Br)N2CCCCS2(=O)=O)C(=O)NCC3=CC(=CC(=C3)F)F	Ki ~ 100000 nM	Poor binder
T93509	Calcitonin gene-related peptide 1	B8EN4P	2-[4-Bromo-5-hydroxy-6-[(3,5-difluorobenzyl)carbamoyl]-2-pyridinyl]tetrahydro-2H-1,2-thiazine 1,1-dioxide	Investigative	9847811	C17H16BrF2N3O4S	476.3	C1CCS(=O)(=O)N(C1)C2=NC(=C(C(=C2)Br)O)C(=O)NCC3=CC(=CC(=C3)F)F	Ki ~ 100000 nM	Poor binder
T93509	Calcitonin gene-related peptide 1	BGR3T4	5-(1,1-Dioxothiazinan-2-yl)-N-[(4-fluorophenyl)methyl]-1,6-naphthyridine-7-carboxamide	Investigative	57393755	C20H19FN4O3S	414.5	C1CCS(=O)(=O)N(C1)C2=C3C=CC=NC3=CC(=N2)C(=O)NCC4=CC=C(C=C4)F	Ki ~ 100000 nM	Poor binder
T93509	Calcitonin gene-related peptide 1	BWB1F2	N-[(3,5-Difluorophenyl)methyl]-5-(1,1-dioxothiazinan-2-yl)-8-hydroxyquinoline-7-carboxamide	Investigative	57392039	C21H19F2N3O4S	447.5	C1CCS(=O)(=O)N(C1)C2=C3C=CC=NC3=C(C(=C2)C(=O)NCC4=CC(=CC(=C4)F)F)O	Ki ~ 100000 nM	Poor binder
T93509	Calcitonin gene-related peptide 1	BY08OQ	(3,5-Difluorophenyl)methyl 5-(1,1-dioxothiazinan-2-yl)-8-hydroxy-1,6-naphthyridine-7-carboxylate	Investigative	57402496	C20H17F2N3O5S	449.4	C1CCS(=O)(=O)N(C1)C2=NC(=C(C3=C2C=CC=N3)O)C(=O)OCC4=CC(=CC(=C4)F)F	Ki ~ 100000 nM	Poor binder